Aimee E. Houlton

505 total citations
9 papers, 79 citations indexed

About

Aimee E. Houlton is a scholar working on Genetics, Epidemiology and Hematology. According to data from OpenAlex, Aimee E. Houlton has authored 9 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Aimee E. Houlton's work include Acute Myeloid Leukemia Research (2 papers), Acute Ischemic Stroke Management (2 papers) and Intracerebral and Subarachnoid Hemorrhage Research (2 papers). Aimee E. Houlton is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Acute Ischemic Stroke Management (2 papers) and Intracerebral and Subarachnoid Hemorrhage Research (2 papers). Aimee E. Houlton collaborates with scholars based in United Kingdom, Australia and Italy. Aimee E. Houlton's co-authors include Joanna M. Wardlaw, Philip M. Bath, Nikola Sprigg, Lisa J Woodhouse, Kailash Krishnan, Keith Wheatley, Alessandro Adami, Jennifer Becker, Panos Koumellis and Elizabeth Walker and has published in prestigious journals such as Blood, Journal of Neurology Neurosurgery & Psychiatry and Archives of Disease in Childhood.

In The Last Decade

Aimee E. Houlton

9 papers receiving 79 citations

Peers

Aimee E. Houlton
Shahid Waheed Pakistan
Běla Malinová Czechia
Nawaz Walji United Kingdom
Y Onishi Japan
Damir Muhvić Croatia
Nicholas Whipple United States
Yapeng Lin China
Fernando Contreras Mejía Colombia
Yifan Hong China
Eleonóra Klímová Slovakia
Shahid Waheed Pakistan
Aimee E. Houlton
Citations per year, relative to Aimee E. Houlton Aimee E. Houlton (= 1×) peers Shahid Waheed

Countries citing papers authored by Aimee E. Houlton

Since Specialization
Citations

This map shows the geographic impact of Aimee E. Houlton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee E. Houlton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee E. Houlton more than expected).

Fields of papers citing papers by Aimee E. Houlton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee E. Houlton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee E. Houlton. The network helps show where Aimee E. Houlton may publish in the future.

Co-authorship network of co-authors of Aimee E. Houlton

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee E. Houlton. A scholar is included among the top collaborators of Aimee E. Houlton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee E. Houlton. Aimee E. Houlton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bate, Jessica, Stephen Baker, Judith Breuer, et al.. (2018). PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Archives of Disease in Childhood. 104(1). 25–29. 7 indexed citations
2.
Craddock, Charles, Lynn Quek, Aimee E. Houlton, et al.. (2017). MOLECULAR PREDICTORS OF RESPONSE TO AZACITIDINE THERAPY: THE RESULTS OF THE UK TRIALS ACCELERATION PROGRAMME RAVVA STUDY. Haematologica. 102. 323–323. 4 indexed citations
3.
Fox, Stephen B., Christina Yap, Aimee E. Houlton, et al.. (2016). RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL. Haematologica. 101. 97–97. 1 indexed citations
4.
5.
Krishnan, Kailash, Aimee E. Houlton, Elizabeth Walker, et al.. (2015). Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Journal of Neurology Neurosurgery & Psychiatry. 86(11). 1258–1266. 26 indexed citations
6.
7.
8.
Houlton, Aimee E., James Nevin, Janos Balega, et al.. (2015). Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer. International Journal of Gynecological Cancer. 25(9). 1599–1607. 16 indexed citations
9.
Bath, Philip M., et al.. (2014). Statistical Analysis Plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) Trial. International Journal of Stroke. 9(3). 372–374. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahid Waheed Breakdown of academic impact, for papers by Běla Malinová Breakdown of academic impact, for papers by Nawaz Walji Breakdown of academic impact, for papers by Y Onishi Breakdown of academic impact, for papers by Damir Muhvić Breakdown of academic impact, for papers by Nicholas Whipple Breakdown of academic impact, for papers by Yapeng Lin Breakdown of academic impact, for papers by Fernando Contreras Mejía Breakdown of academic impact, for papers by Yifan Hong Breakdown of academic impact, for papers by Eleonóra Klímová
Rankless by CCL
2026